Beclometasone Dipropionate Aqueous Nasal Spray, 50 micrograms per spray Malta - English - Medicines Authority

beclometasone dipropionate aqueous nasal spray, 50 micrograms per spray

generics uk limited station close, potters bar, herts, en6 1tl, united kingdom - beclometasone dipropionate - nasal spray, solution - beclometasone dipropionate 50 µg - nasal preparations

QVAR 100 AUTOHALER beclometasone dipropionate    100mcg per actuation pressurised inhalation Australia - English - Department of Health (Therapeutic Goods Administration)

qvar 100 autohaler beclometasone dipropionate 100mcg per actuation pressurised inhalation

inova pharmaceuticals (australia) pty ltd - beclometasone dipropionate, quantity: 0.1 mg/actuation - inhalation, pressurised - excipient ingredients: ethanol; norflurane - qvar is indicated for the prophylactic management of asthma.

QVAR 100 INHALER beclometasone dipropionate      100mcg per actuation pressurised inhalation Australia - English - Department of Health (Therapeutic Goods Administration)

qvar 100 inhaler beclometasone dipropionate 100mcg per actuation pressurised inhalation

inova pharmaceuticals (australia) pty ltd - beclometasone dipropionate, quantity: 0.1 mg/actuation - inhalation, pressurised - excipient ingredients: ethanol; norflurane - prophylactic management of asthma.

Alanase 100 New Zealand - English - Medsafe (Medicines Safety Authority)

alanase 100

viatris limited - beclometasone dipropionate 1 mg/g;   - nasal spray solution - 100 mcg/dose - active: beclometasone dipropionate 1 mg/g   excipient: benzalkonium chloride dispersible cellulose glucose phenethyl alcohol polysorbate 80 purified water - alanase 100 aqueous nasal spray (100 µg per actuation) is indicated for the prevention and treatment of seasonal and perennial allergic rhinitis and vasomotor rhinitis. alanase 100 can significantly delay the recurrence of nasal polyps in those patients who have undergone nasal polypectomy. in those polyps that do recur, alanase 100 can suppress their increase in size.

BECONASE ALLERGY & HAYFEVER beclometasone dipropionate 0.5mg/g (50 micrograms per actuation) aqueous nasal spray bottle Australia - English - Department of Health (Therapeutic Goods Administration)

beconase allergy & hayfever beclometasone dipropionate 0.5mg/g (50 micrograms per actuation) aqueous nasal spray bottle

viatris pty ltd - beclometasone dipropionate, quantity: 500 microgram/g - spray, nasal - excipient ingredients: hydrochloric acid; purified water; benzalkonium chloride; phenethyl alcohol; polysorbate 80; dispersible cellulose; glucose - for the prophylaxis or treatment of allergic rhinitis for up to 6 months in adults and children 12 years and over.

BecloClear100 New Zealand - English - Medsafe (Medicines Safety Authority)

becloclear100

aft pharmaceuticals ltd - beclometasone dipropionate 1 mg/g equivalent to beclometasone dipropionate 100 mcg per spray - nasal spray solution - 100 mcg/dose - active: beclometasone dipropionate 1 mg/g equivalent to beclometasone dipropionate 100 mcg per spray excipient: benzalkonium chloride dispersible cellulose glucose hydrochloric acid phenethyl alcohol polysorbate 80 purified water - becloclear 100 is indicated in adults and children over six years of age for the prevention and treatment of seasonal and perennial allergic rhinitis and vasomotor rhinitis. becloclear 100 can significantly delay the recurrence of nasal polyps in those patients who have undergone nasal polypectomy. in those polyps that do recur, becloclear 100 can suppress their increase in size.

FOSTAIR 100/6 beclometasone dipropionate 100 microgram and formoterol fumarate dihydrate 6 microgram  pressurised inhalation solution Australia - English - Department of Health (Therapeutic Goods Administration)

fostair 100/6 beclometasone dipropionate 100 microgram and formoterol fumarate dihydrate 6 microgram pressurised inhalation solution

chiesi australia pty ltd - beclometasone dipropionate, quantity: 100 microgram; formoterol fumarate dihydrate, quantity: 6 microgram - inhalation, pressurised - excipient ingredients: norflurane; ethanol absolute; hydrochloric acid - asthma fostair is indicated in adults (18 years and older) in the treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids (ics) and 'as needed' inhaled rapid-acting beta2-agonist or - patients already adequately controlled on both ics and long-acting beta2-agonists (laba). (see section 4.2 dose and method of administration for treatment approaches). copd (fostair 100/6 only) symptomatic treatment of adults with severe copd (fev1 less than 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.